Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Voyager Therapeutics
VYGR
$201M
| $6.62M | ﹤0.01% |
524,758
+408,507
| +351% | +$4.75M |
|
2552
PUT
GameStop
GME
$8.37B
| $6.6M | ﹤0.01% |
6,083,600
+2,445,200
| +67% | +$2.82M |
|
2553
CALL
Nektar Therapeutics
NKTR
$2.49B
| $6.56M | ﹤0.01% |
18,880
-1,253
| -6% | -$391K |
|
2554
CALL
AvalonBay Communities
AVB
$26.3B
| $6.56M | ﹤0.01% |
42,400
+600
| +1% | +$94.9K |
|
|
TBIO
2555
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $6.56M | ﹤0.01% |
365,824
+341,071
| +1,378% | +$5.14M |
|
2556
Texas Pacific Land
TPL
$24.7B
| $6.55M | ﹤0.01% |
99,153
-131,526
| -57% | -$8.08M |
|
|
MRTX
2557
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.55M | ﹤0.01% |
57,382
-27,615
| -32% | -$2.68M |
|
2558
CGI
GIB
$15.2B
| $6.55M | ﹤0.01% |
104,015
-30,419
| -23% | -$1.9M |
|
2559
Ares Management
ARES
$32.5B
| $6.54M | ﹤0.01% |
164,775
+128,209
| +351% | +$4.53M |
|
2560
CALL
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $6.54M | ﹤0.01% |
71,400
-35,500
| -33% | -$3.25M |
|
2561
Constellium
CSTM
$4.01B
| $6.53M | ﹤0.01% |
850,052
+788,666
| +1,285% | +$5.73M |
|
2562
Frontdoor
FTDR
$5.96B
| $6.53M | ﹤0.01% |
147,228
+56,987
| +63% | +$2.33M |
|
2563
Insight Enterprises
NSIT
$4.53B
| $6.52M | ﹤0.01% |
132,449
-7,228
| -5% | -$356K |
|
|
DEA
2564
Easterly Government Properties
DEA
$1.17B
| $6.51M | ﹤0.01% |
112,714
+92,816
| +466% | +$5.89M |
|
2565
Tenaris
TS
$27B
| $6.51M | ﹤0.01% |
503,771
-1,359,567
| -73% | -$18M |
|
2566
iShares US Treasury Bond ETF
GOVT
$43.7B
| $6.51M | ﹤0.01% |
232,670
-73,056
| -24% | -$2.04M |
|
2567
PUT
Wingstop
WING
$3.44B
| $6.5M | ﹤0.01% |
46,800
+400
| +0.9% | +$46.6K |
|
2568
CALL
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$329M
| $6.5M | ﹤0.01% |
8,322
+3,479
| +72% | +$3.51M |
|
|
MRSH
2569
CALL
Marsh
MRSH
$89.6B
| $6.49M | ﹤0.01% |
60,400
+44,600
| +282% | +$4.51M |
|
2570
Fabrinet
FN
$20.4B
| $6.48M | ﹤0.01% |
103,872
-394,479
| -79% | -$24.2M |
|
2571
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $6.48M | ﹤0.01% |
163,600
+13,900
| +9% | +$515K |
|
|
ISDX
2572
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic Developed ex-US ETF
ISDX
| $6.47M | ﹤0.01% |
297,341
+78,323
| +36% | +$1.62M |
|
2573
CALL
Hartford Financial Services
HIG
$37.8B
| $6.47M | ﹤0.01% |
167,900
+72,200
| +75% | +$2.75M |
|
|
INFN
2574
PUT
DELISTED
Infinera Corporation Common Stock
INFN
| $6.46M | ﹤0.01% |
1,091,400
+63,300
| +6% | +$347K |
|
2575
CALL
iShares US Aerospace & Defense ETF
ITA
$15.1B
| $6.46M | ﹤0.01% |
78,400
+27,000
| +53% | +$2.13M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.